1. Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace 

2. Roche Corporate Principles Mission Our aim as a leading healthcare company is to create, produce and market innovative solutions of high quality for unmet medical needs. Our products and services help to prevent, diagnose and treat diseases, thus enhancing people’s health and quality of life. We do this in a responsible and ethical manner and with a commitment to sustainable development respecting the needs of the individual, the society and the environment. 

3. CNS -1 % Infectious diseases -6 % Virology +3 % Other -5 % Oncology +33 % Dermatology -13 % Transplantation +17 % Anaemia +79 % Metabolic disorders -2% Inflammation/ bone -9 % Cardiovascular +8 % Roche Divisions / Pharmaceuticals Prescription sales 2002 by therapeutic area 

4. R&D / Diagnostics Leveraging: Competencies and Resources Research Field Professionals Consumers Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care Industrial Biochemicals Harmonized systems platforms LightCycler Extensions Protein Expression Viral Load Monitoring Blood Screening Menu Extension Single Strip System Integrated Spot Monitoring BG/ Electrolyte Extensions Continuous Monitoring Automated Pancreas Primary Care System Genomics / Proteomics New diagnostic markers PCR Microbiology/Sepsis Integrated Cancer Care Micro / Nano Technologies (microarrays /microfluidics) Informatics 

5. Roche Key Figures  Sales:29.7 Billion CHF R&D: 4.3 Billion CHF Employees:69,700 Europe 47% North America 26% Asia 16% Latin America 8% Other 3% More Information at www.Roche.com

6. Roche EH&S Key Figures  11th Year of EH&S Public Reporting (Since 1992) 5th Year of Third Party Verification of Report by PWC Eco-Efficiency Indicators (compared to sales) 1992 - 2001 Energy Usage - 46.5% CO 2 emissions -60.5% VOC emissions -79.6% Chemical Wastes - 65.0%

7. WEC CSR Indicator Screen Brings together many Sustainable Development Charters Allows weighting of Indicators based on importance to company and stakeholder Our dilemma - how to rank the importance to our stakeholders 

8. Key Issues for Financial & NGO Communities Selection of similar indicators Database for comparing results Clear Definitions Third Party Verification 

9. Corporate Citizenship Measures Should be Well Defined Consistent Audited / Verified 